---
title: "Stoke Therapeutics to present at Canaccord Genuity Annual Growth Conference"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294962990.md"
description: "Stoke Therapeutics will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at 11:00 a.m. ET. CEO Ian F. Smith and Chief Patient Officer Jason Hoitt will lead the presentation."
datetime: "2026-08-05T12:02:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294962990.md)
  - [en](https://longbridge.com/en/news/294962990.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294962990.md)
generator: "portal-rs"
---

# Stoke Therapeutics to present at Canaccord Genuity Annual Growth Conference

-   Stoke Therapeutics will present at the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, 2026 at 11:00 a.m. ET. \* CEO Ian F. Smith will present alongside Chief Patient Officer Jason Hoitt. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608050800BIZWIRE\_USPR\_\_\_\_\_20260805\_BW048411) on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [STOK.US](https://longbridge.com/en/quote/STOK.US.md)

## Related News & Research

- [Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | STOK Stock News](https://longbridge.com/en/news/296264806.md)
- [Stoke Therapeutics files for at-the-market offering of up to $200 million in stock](https://longbridge.com/en/news/294739210.md)
- [Canaccord Genuity agrees to acquire EFG Harris Allday teams and client assets in UK](https://longbridge.com/en/news/296271288.md)
- [ReNew Energy Global warrants set to be delisted after expiration](https://longbridge.com/en/news/296360098.md)
- [Stoke Therapeutics CMO Barry Ticho disposes of USD 208,707 in common shares](https://longbridge.com/en/news/295009097.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**